Advisory Board

JFK Johnson Rehabilitation Institute
ABMS, Brain Injury Medicine Certified
Medical Director: Stroke Recovery, Post-COVID Rehabilitation & Aftercare

Programs
Clinical Associate Professor, Rutgers Robert Wood Johnson Medical School
Core Assistant Professor, Hackensack Meridian School of Medicine

Dr. Talya Fleming is the Medical Director of the Stroke Recovery Program, Post-COVID Rehabilitation
Program & Aftercare Programs at JFK Johnson Rehabilitation Institute. Dr. Fleming earned her
undergraduate degree from Rutgers University in New Brunswick with a major in Biological Sciences and a minor in Spanish. She obtained her medical degree from Robert Wood Johnson Medical School and completed residency training at JFK Johnson Rehabilitation Institute. Dr. Fleming is double board certified in Physical Medicine and Rehabilitation as well as Brain Injury Medicine from the American Board of Medical Specialties. She is a Clinical Assistant Professor at Rutgers Robert Wood Johnson Medical School and Core Assistant Professor at Hackensack Meridian School of Medicine.

Interested in the role of exercise and disability, she presents her clinical research nationally and
internationally on the topics of stroke rehabilitation, modified cardiac rehabilitation for stroke survivors,
neurorehabilitation, post-acute transitions of care and healthcare delivery. She has been integral in the
creation, design and implementation of the JFK Johnson Stroke Recovery Program and related Stroke-
HEART(TM) Trials from their inception.

Dr. Fleming has achieved many professional accomplishments in her career including professional awards, authorships and grants. Dr. Fleming has been invited to speak at prestigious national and international conferences including:  The American Heart Association and American Stroke Association (AHA/ASA) Scientific Sessions, American Congress of Rehabilitation Medicine (ACRM), American Academy of Physical Medicine and Rehabilitation (AAPM&R), Association of Academic Physiatrists (AAP), International Society of Physical and Rehabilitation Medicine (ISPRM), and the Association of American Medical Colleges (AAMC).

Dr. Fleming is also a selected member of several national strategic leadership committees addressing
stroke, COVID-19 and disparities in medicine. She is a member of the American Congress of Rehabilitation Medicine Stroke Interdisciplinary Stroke Interest Group – Health and Wellness Task Force which promotes health management and health maintenance after stroke. During its tenure, she was also a member of the Association of Academic Physiatrists (AAP) Women in Academic Physiatry Presidential Task Force with the goal to examine gender bias in leadership positions in women in medicine.

Pediatric and Adult Physiatry

Dr. Cheng is board-certified in both Physical Medicine and Rehabilitation and Pediatric Rehabilitation Medicine. Dr. Cheng served as Chief of Physiatry at Children’s Specialized Hospital for seven years until 2021 when he established his private practice, Pediatric Rehabilitation Specialists LLC (www.peds.rehab). He earned his B.A. in Psychology from Princeton University and a second B.A. in Molecular, Cellular and Developmental Biology from the University of California-Santa Cruz. He continued his education at Rutgers-New Jersey Medical School. Dr. Cheng completed his internship at St. Barnabas Medical Center and his residency in Physical Medicine and Rehabilitation at Rutgers-New Jersey Medical School/Kessler Institute for Rehabilitation. He completed two additional years of fellowship training in Pediatric Rehabilitation Medicine at Children’s Specialized Hospital. 

Dr. Cheng has special interests in the treatment of children with Cerebral Palsy and Spasticity Management as well as Adaptive Sports and Recreation. He has lectured nationally on these subjects.

Dr. Cheng has a strong connection to his community, volunteering for several non-profit organizations. He is the founder of Peak Potential, Inc., an entirely volunteer-run charity that provides free, adaptive rock climbing programs for children with physical disabilities. He also served as medical advisor and divemaster for Stay-Focused, Inc., a non-profit organization that provides adaptive SCUBA diving programs for young adults with mobility challenges.

Learn more about Dr. Cheng: www.jenfuchengmd.com.

Managing Director, AI and Data Analytics 
DLA Piper
 

Steve Henn is a senior executive with 30 years of experience in financial, operational, legal, and general management in a wide range of industries. He is currently managing DLA Piper’s new Artificial Intelligence and Data Analytics Professional Services Practice to help the firm and its clients leverage AI and other advanced technologies to build strategic competitive advantages, increase revenue growth, and drive efficiency. 

He is a recognized expert in business ethics and the author of Business Ethics: A Case Study Approach and a contributing author to the World Book of Values (Van Halewyck, 2013). Steve has spoken in the US and aboard on topics such as ethics and professionalism; law and technology; artificial intelligence and cognitive analytics, as well as business management and growth. 

In 2013, Steve started to focus on artificial intelligence, cognitive analytics and the use of advanced technologies in the analysis and management of risk. Since then, he has pioneered the use of AI and data analytic solutions in the areas of data privacy, governance, and contracts for functions as diverse as information security, data governance, mergers and acquisitions, legal operations and human resources. Steve has addressed a wide variety of industries, including healthcare, banking, insurance, telecommunications and media, airlines, and logistics. 

Prior to DLA Piper, Steve was the Chief Revenue Officer of EXTEND Resources,  Vice President of Consulting and Analytics for Conduent, Inc. where he led the development of several industry leading artificial intelligence products, President and CEO of UBIC, North America, a global artificial intelligence company focused on governance, risk, compliance, and eDiscovery, President of eMag Solutions, LLC; of SmartPros Legal & Ethics, Ltd., and of Cognistar Corporation. 

Steve is a panel reviewer for the National Science Foundation for artificial intelligence applications and an adjunct professor at Sacred Heart University. He is a member of the Connecticut bar. 

Dr. Nancy Kirsch is currently the Vice Chairperson for Administration of the Rehabilitation and Movement Sciences Department and the Director of the Doctor of Physical Therapy Programs at Rutgers, The State University of New Jersey. She is currently a member of the New Jersey Board of Physical Therapy Examiners and President of the Board of Directors of the Federation of State Boards of Physical Therapy (FSBPT).

Dr. Kirsch has pioneered the field of Physical Therapy and has been active in the American Physical Therapy Association (APTA) since she was a student. She was President and Chief Delegate of the NJ Chapter and served a five year term on the APTA Ethics and Judicial Committee, including a term as Chairperson and a three year term on the Reference Committee including a term as Chairperson. She served the national association as a member of the Ethics Document Revision Task Force and Scope of Practice and Imaging Task Force, most recently serving on the Clinical Education Task Force Report and The Commission on Accreditation in Physical Therapy Education (CAPTE) Standards and Required Elements Revision Task Force. Consequently, she has deep knowledge and understanding of the regulatory landscape in physical therapy.

Dr. Kirsch holds over 30 years’ experience in health administration, physical therapy regulations and practice. She began her career as staff Physical Therapist at Kessler Institute in New Jersey and has held positions as supervisor, director, and vice president at various renowned hospitals and institutions. 1989 she founded a private Physical Therapy practice together with two other women, and she is still a practicing physical therapist as well as a tenured professor at Rutgers. Her research interests center around providing safe and effective physical therapy care to patients. This includes professional growth, ethical behavior, and risk based regulation.

She was awarded the APTA Lucy Blair Service Award in 2006 and became a Catherine Worthingham Fellow in 2014. She received the Outstanding Service Award and President’s Award from Federation of State Boards of Physical Therapy (FSBPT). She received the Distinguished Professional Award from the New Jersey Chapter of the APTA in 2017.

Dr. Kirsch writes a column about ethics in the APTA publication PT in Motion called Ethics in Action and recently published a textbook entitled Ethics in Physical Therapy: A Case Based Approach.

Jennifer brings over 20 years of extensive experience in the Medical Device, MedTech, and Pharmaceutical space. She has a remarkable background, for the past 6 years, Jennifer worked with Global Marketing as well as served as the Vice President for the Cardiac Assist Global Product Area at Getinge. Before that she spent 13 years at Johnson and Johnson Ethicon, where she excelled in marketing and professional education within the Cardiovascular and Gynecologic surgical domains. Additionally, she has worked in market development for Oncology Diagnostics at both Janssen and Bristol-Myers Squibb. 

In her role as an Advisor to NeuroTechR3, Jennifer will provide guidance to the Executive Team in formulating effective business strategies, navigating regulatory pathways, and identifying customer acquisition channels. Her expertise will be instrumental in preparing the company’s product portfolio for successful market launch. 

Scott brings a wealth of experience in healthcare corporate and investment banking, most recently as Head of Healthcare Corporate Banking at Deutsche Bank Securities. He currently is a co-founder of Materium Technologies in New Jersey.

With over two decades of experience providing strategic and financial advice to global corporations, Scott’s addition to our team is a significant step forward. His track record of managing complex financial transactions and building client relationships will be instrumental to our new product launches and continued innovations in the field of neurotechnology.

Scott’s impressive background includes his service in the U.S. Navy, where he was decorated for his actions in the Persian Gulf during Operation Desert Storm. He graduated from Duke University, has an MBA from the University of Chicago Booth School of Business, and has completed a Master’s Degree from NJIT in Artificial Intelligence.

As we continue to improve patient outcomes and explore new frontiers in rehabilitation, the addition of Scott’s strategic advice and insights will be invaluable in shaping the company’s success. 

Scroll to top